MRSH
Marsh McLennan
$160.12
▼ 1.4%Updated Today 7:15 PM ET
▼ Down 24.2% over the last 12 months
Market Cap
$78.25B
P/E
19.85x
Forward P/E (est.)
20.25x
ROE
25.9%
Revenue Growth
9.9%
EPS Growth
-2.0%
Profit Margin
14.3%
FCF Yield
—
Debt / Equity
1.3x
ROIC
31.0%
Interest Coverage
10.77x
Current Ratio
1.11x
Dividend Yield
2.2%
Implied Growth (rev. DCF)
2.5%
Rating Score
55/100
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what MRSH's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. MRSH trades near $160.12, below its 50-day average ($167.06) and 200-day average ($180.93). Price below both averages is a downtrend — momentum is against buyers for now.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 58 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently positive — short-term momentum is improving.
Volatility — ATR. Average True Range is the typical daily move. MRSH's is $3.76 (~2.3% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month MRSH found buyers near $156.60 (support) and sellers near $170.15 (resistance); its 52-week range is $156.60–$220.32. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.9× the 20-day average — about normal. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
Marsh McLennan (MRSH) is a large-cap company in the Insurance Brokers industry, part of the Financials sector of the S&P 500, with a market value around $78.25B.
In its latest reported year it generated about $26.98B in revenue and $4.16B in net profit.
Our model rates MRSH Neutral (55/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
3Y CAGR
9.2%
Revenue moved from $20.72B in 2022 to $26.98B in 2025, a 9.2% compound annual growth rate. The most recent year grew a steady 9.9% year over year. Slower, mature growth is common for established businesses.
Gross Margin
—
Operating Margin
23.1%
Net Margin
15.4%
ROE
25.9%
Marsh McLennan keeps about 14.3% of each sales dollar as net profit. Return on equity is 25.9% and return on invested capital about 31.0%. Margins are moderate — typical of a competitive but profitable business.
Total Debt
$19.55B
Net Debt
$17.94B
Net Debt / EBITDA
2.88x
Debt / Equity
1.3x
Leverage: debt-to-equity is 1.3x, and operating profit covers interest about 10.8x, with a current ratio of 1.1x. That is a moderate, manageable debt load for most businesses. It carries roughly $19.55B of total debt against $1.61B of cash.
Operating CF
$5.29B
Free Cash Flow
$5.00B
FCF Margin
18.5%
In the latest year Marsh McLennan produced about $5.29B of operating cash flow and $5.00B of free cash flow after capital spending. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.
P/E
19.85x
P/S
2.96x
P/B
5.71x
EV / EBITDA
14.93x
MRSH trades at 19.8x trailing earnings (about 20.3x on estimated forward earnings), 3.0x sales, and 5.7x book value. Reverse-engineering today's price implies the market expects roughly 2.5% long-term free-cash-flow growth. That is a fairly typical valuation for a profitable company.
Where this stock sits versus what most companies trade at.
Typical ranges are general references (e.g., many stocks trade at ~18–26x earnings), not hard rules. Context only — not investment advice.
How MRSH stacks up against its Financials peers — valuation, profitability, and growth versus the sector median.
In the Financials sector (76 S&P 500 companies), MRSH ranks #61 of 76 by our overall rating. It trades at a premium versus the sector on earnings (19.8x P/E vs. 15.2x median) with a higher return on equity (25.9% vs. 15.3%) and faster revenue growth (9.9% vs. 9.1%).
P/E vs sector
19.8x
median 15.2x
ROE vs sector
25.9%
median 15.3%
Growth vs sector
9.9%
median 9.1%
Sector rank
#61
of 76 by rating
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Financials companies by sub-industry and size. Sector median is across all 76 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$162.34 – $270.57
vs. $160.12 today · expected CAGR 0% – 11%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $29.68B | $32.65B | $35.91B | $39.50B | $43.45B |
| Net income | $4.45B | $4.90B | $5.39B | $5.93B | $6.52B |
| EPS | $9.24 | $10.16 | $11.18 | $12.30 | $13.53 |
| Share price (low) | $110.88 | $121.97 | $134.17 | $147.58 | $162.34 |
| Share price (high) | $184.80 | $203.28 | $223.61 | $245.97 | $270.57 |
| CAGR (low–high) | -31% / 15% | -13% / 13% | -6% / 12% | -2% / 11% | 0% / 11% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for MRSH:
- Strong return on equity (25.9%) shows capital is put to work well.
- Pays a 2.2% dividend on top of any price gains.
The case against MRSH:
- Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Balance-sheet risk — debt/equity of 1.3x magnifies the impact of higher rates or weaker earnings.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the picture is mixed: Marsh McLennan is a large-cap financials business growing at a mature pace, with solid profitability, and a heavier debt load to watch. It trades at 19.8x earnings, which our model scores Neutral (55/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.